Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Reeti Joshi"'
Autor:
Prashanth Sunkureddi, Dominick Latremouille-Viau, Mark K. Meiselbach, Jipan Xie, Peter Hur, Reeti Joshi
Publikováno v:
Rheumatology and Therapy, Vol 6, Iss 1, Pp 89-100 (2019)
Abstract Introduction Secukinumab is a fully human anti-interleukin 17A monoclonal antibody approved for the treatment of psoriatic arthritis (PsA) in the United States. Few studies have investigated prescribing patterns among rheumatologists who hav
Externí odkaz:
https://doaj.org/article/a79c8d4d9b9846c5b5418b3ca3095672
Autor:
Reeti Joshi, Dominick Latremouille-Viau, Mark K. Meiselbach, Jipan Xie, Yujin Park, Prashanth Sunkureddi
Publikováno v:
Drugs - Real World Outcomes, Vol 6, Iss 1, Pp 1-9 (2019)
Abstract Objectives To characterize US patients with ankylosing spondylitis (AS) who were treated with secukinumab and to assess rheumatologist-reported reasons for prescribing treatment in clinical practice. Methods This descriptive analysis of data
Externí odkaz:
https://doaj.org/article/62e387acb27e4aecb804402811657616
Autor:
Prashanth Sunkureddi, Jipan Xie, Dominick Latremouille-Viau, Reeti Joshi, Yujin Park, Mark K. Meiselbach
Publikováno v:
Drugs-Real World Outcomes
Drugs-Real World Outcomes, Vol 6, Iss 1, Pp 1-9 (2019)
Drugs-Real World Outcomes, Vol 6, Iss 1, Pp 1-9 (2019)
Objectives To characterize US patients with ankylosing spondylitis (AS) who were treated with secukinumab and to assess rheumatologist-reported reasons for prescribing treatment in clinical practice. Methods This descriptive analysis of data from a U
Autor:
Peter Hur, Reeti Joshi, Jipan Xie, Dominick Latremouille-Viau, Prashanth Sunkureddi, Mark K. Meiselbach
Publikováno v:
Rheumatology and Therapy
Rheumatology and Therapy, Vol 6, Iss 1, Pp 89-100 (2019)
Rheumatology and Therapy, Vol 6, Iss 1, Pp 89-100 (2019)
Introduction Secukinumab is a fully human anti-interleukin 17A monoclonal antibody approved for the treatment of psoriatic arthritis (PsA) in the United States. Few studies have investigated prescribing patterns among rheumatologists who have initiat
Autor:
B. Paul Wordsworth, David M. Evans, Michael H. Weisman, Reeti Joshi, Shervin Assassi, Matthew A. Brown, Michael M. Ward, Lianne S. Gensler, John D. Reveille
Publikováno v:
Arthritis Care & Research. 64:780-784
Objective Several genetic risk variants for ankylosing spondylitis (AS) have been identified in genome wide association studies. Our objective was to examine whether familial AS cases have a higher genetic load of these susceptibility variants.
Autor:
Mamta K. Jain, He Jun Yuan, Nahid Attar, Emmanuel Seremba, Reeti Joshi, Doan Dao, William M. Lee, Rafia Bhore
Publikováno v:
AIDS Patient Care and STDs. 26:73-80
Noninvasive markers of liver fibrosis, measured at baseline, have been shown to predict liver-related mortality. It remains unknown if a change in the value of the scores over time predicts mortality in patients with HIV and viral hepatitis. In this
Publikováno v:
Rheumatology international. 35(9)
Patients with rheumatoid arthritis (RA) are at increased risk of infection. In this study, we determined the risk of and risk factors for Staphyococcus aureus (S. aureus) sepsis in RA. We assembled a retrospective nested case–control subset of RA p
Publikováno v:
The Journal of Rheumatology. 38:1525-1526
To the Editor: Tophaceous gout of the axial skeleton is an unusual presentation. Most cases occur in men with a history of severe polyarticular gout1. In reported cases, patients have usually presented with symptoms including neck and back pain, radi